by mroseboro | Mar 12, 2019 |
MagnifyThe Next Generation Incubator KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA’s lead product, KYBELLA™, is the...
by vittorio | Mar 11, 2019 |
MyoGene Bio is developing cutting edge therapeutics for muscle diseases, starting with a gene editing therapy for Duchenne muscular dystrophy. Market:Duchenne muscular dystrophy (DMD) is a severe, progressive muscle wasting disorder that affects approximately 1 in...
by vittorio | Mar 11, 2019 |
Myst Therapeutics, Inc. is developing novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy solid tumor cancer cells. Market:Over 400,000 Americans die from cancer every year, with roughly 10% being blood cancers...
by emilybrown | Dec 28, 2016
Scarless Laboratories is an early-stage biotechnology company with a mission to develop safe and effective therapies for scar minimization and wound healing. Market:There are no approved drug-based therapies for improvement in scar appearance, wound tensile strength...
Recent Comments